home All News open_in_new Full Article

Grifols pagará hasta 347 millones para excluir de Bolsa a Biotest

El supervisor alemán aprueba la operación y se inicia el periodo de aceptación de la opa lanzada por el grupo farmacéutico el 31 de marzo. La Ibex ya controla el 97,41% de las acciones ordinarias de Biotest y el 46,33% de los títulos preferentes. Leer


today 5 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Events
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Events
attach_file Events
attach_file Politics
attach_file Society
attach_file Politics
attach_file Politics


ID: 3525919812
Add Watch Country

arrow_drop_down